Cingulate Inc. Warrants
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CINGW and buy or sell other stocks, ETFs, and their options commission-free!About CINGW
Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD).
CEOJennifer L. Callahan, CPA
CEOJennifer L. Callahan, CPA
Employees—
Employees—
HeadquartersKansas City, Kansas
HeadquartersKansas City, Kansas
Founded2013
Founded2013
Employees—
Employees—
CINGW Key Statistics
Market cap—
Market cap—
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume23.88K
Average volume23.88K
High today$0.055
High today$0.055
Low today$0.0499
Low today$0.0499
Open price$0.0499
Open price$0.0499
Volume156.90K
Volume156.90K
52 Week high$0.175
52 Week high$0.175
52 Week low$0.02
52 Week low$0.02
Stock Snapshot
The current Cingulate Inc. Warrants(CINGW) stock price is $0.05.
On 2025-12-11, Cingulate Inc. Warrants(CINGW) stock moved within a range of $0.05 to $0.06. With shares now at $0.05, the stock is trading +10.0% above its intraday low and -0.2% below the session's peak.
Trading activity shows a volume of 156.9K, compared to an average daily volume of 23.88K.
The stock's 52-week range extends from a low of $0.02 to a high of $0.18.
The stock's 52-week range extends from a low of $0.02 to a high of $0.18.